Global Focused Ultrasound Tumor Therapeutic Systems Market Growth 2024-2030

Report ID: 2888481 | Published Date: Jan 2026 | No. of Page: 125 | Base Year: 2025 | Rating: 4 | Webstory: Check our Web story

Impact of U.S Tarrifs Analyzed 2025

Focused ultrasound therapy systems are medical devices that use focused ultrasound energy to non-invasively treat a variety of medical conditions. This technology, also known as high-intensity focused ultrasound (HIFU), delivers precise and targeted energy to specific tissues within the body, inducing thermal or mechanical effects to achieve therapeutic outcomes.

The global Focused Ultrasound Tumor Therapeutic Systems market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Focused Ultrasound Tumor Therapeutic Systems Industry Forecast” looks at past sales and reviews total world Focused Ultrasound Tumor Therapeutic Systems sales in 2023, providing a comprehensive analysis by region and market sector of projected Focused Ultrasound Tumor Therapeutic Systems sales for 2024 through 2030.

  • With Focused Ultrasound Tumor Therapeutic Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Focused Ultrasound Tumor Therapeutic Systems industry.

This Insight Report provides a comprehensive analysis of the global Focused Ultrasound Tumor Therapeutic Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Focused Ultrasound Tumor Therapeutic Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Focused Ultrasound Tumor Therapeutic Systems market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Focused Ultrasound Tumor Therapeutic Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Focused Ultrasound Tumor Therapeutic Systems.

  1. United States market for Focused Ultrasound Tumor Therapeutic Systems is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
  2. China market for Focused Ultrasound Tumor Therapeutic Systems is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
  3. Europe market for Focused Ultrasound Tumor Therapeutic Systems is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Focused Ultrasound Tumor Therapeutic Systems players cover:

  • Chongqing Haifu Medical Technology
  • Profound Medical
  • InSightec
  • Shanghai A&S
  • Sonablate

In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Focused Ultrasound Tumor Therapeutic Systems market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

  • Ultrasound-Guided
  • MRI-Guided

Segmentation by Application:

  • Hospital
  • Diagnostics Center
  • Others

This report also splits the market by region:

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration:

  • Chongqing Haifu Medical Technology
  • Profound Medical
  • InSightec
  • Shanghai A&S
  • Sonablate
  • EDAP TMS
  • Changjiangyuan Technology Development
  • Theraclion
  • Alpinion Medical Systems
  • Mianyang Sonic Electronic Ltd.
  • NaviFUS
  • SHENZHEN PRO-HIFU MEDICAL

Key Questions Addressed in this Report:

  1. What is the 10-year outlook for the global Focused Ultrasound Tumor Therapeutic Systems market?
  2. What factors are driving Focused Ultrasound Tumor Therapeutic Systems market growth, globally and by region?
  3. Which technologies are poised for the fastest growth by market and region?
  4. How do Focused Ultrasound Tumor Therapeutic Systems market opportunities vary by end market size?
  5. How does Focused Ultrasound Tumor Therapeutic Systems break out by Type, by Application?
Frequently Asked Questions
Focused Ultrasound Tumor Therapeutic Systems report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Focused Ultrasound Tumor Therapeutic Systems report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Focused Ultrasound Tumor Therapeutic Systems report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports